Immunopotentiation of the Humoral Response by Liposomes: Encapsulation Versus Covalent Linkage

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1988 Oct 1

PMID 3192275

Citations 8

Authors

E Shahum

H M Therien

Affiliations

Soon will be listed here.

Abstract

Two different modes of antigen association with liposomes were compared for their stimulation of IgM- and IgG-producing cells in primary- and secondary-response experiments. The study was carried out on BALB/c mice using the antigen bovine serum albumin either free, encapsulated in liposomes or covalently linked to the liposomal surface. Our results indicate that, although both types of liposome association are equally efficient in potentiating the humoral response, encapsulation mainly favours IgG isotype production with little or no effect on the IgM subset, while covalent linkage stimulates the production of both IgG and IgM. Our results reconcile some apparently conflicting published data and suggest that the mode of antigen association with liposomes considerably influences the pathways by which stimulation occurs.

Citing Articles

Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development.

Liang J, Zhao X Cancer Biol Med. 2021; .

PMID: 33979069 PMC: 8185868. DOI: 10.20892/j.issn.2095-3941.2021.0004.

Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

De Serrano L, Burkhart D J Nanobiotechnology. 2017; 15(1):83.

PMID: 29149896 PMC: 5693489. DOI: 10.1186/s12951-017-0319-9.

Modulating the immune system through nanotechnology.

Dacoba T, Olivera A, Torres D, Crecente-Campo J, Alonso M Semin Immunol. 2017; 34:78-102.

PMID: 29032891 PMC: 5774666. DOI: 10.1016/j.smim.2017.09.007.

Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes.

Fox C, Mulligan S, Sung J, Dowling Q, Fung H, Vedvick T Int J Nanomedicine. 2014; 9:1367-77.

PMID: 24648734 PMC: 3956628. DOI: 10.2147/IJN.S56582.

Key roles of adjuvants in modern vaccines.

Reed S, Orr M, Fox C Nat Med. 2013; 19(12):1597-608.

PMID: 24309663 DOI: 10.1038/nm.3409.

References

SWEET G, Welborn F . Use of chromium chloride as the coupling agent in a modified plaque assay. Cells producing anti-protein antibody. J Immunol. 1971; 106(5):1407-10. View

Walden P, Nagy Z, Klein J . Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens. J Mol Cell Immunol. 1986; 2(4):191-7. View

Allison A, Gregoriadis G . Liposomes as immunological adjuvants. Nature. 1974; 252(5480):252. DOI: 10.1038/252252a0. View

Gregoriadis G . Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept. Ann N Y Acad Sci. 1978; 308:343-70. DOI: 10.1111/j.1749-6632.1978.tb22034.x. View

Mimms L, Zampighi G, Nozaki Y, Tanford C, Reynolds J . Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry. 1981; 20(4):833-40. DOI: 10.1021/bi00507a028. View

Lifshitz R, Gitler C, Mozes E . Liposomes as immunological adjuvants in eliciting antibodies specific to the synthetic polypeptide poly(LTyr, LGlu)-poly(DLAla)--(LLys) with high frequency of site-associated idiotypic determinants. Eur J Immunol. 1981; 11(5):398-404. DOI: 10.1002/eji.1830110510. View

Shek P, Sabiston B . Immune response mediated by liposome-associated protein antigens. I. Potentiation of the plaque-forming cell response. Immunology. 1982; 45(2):349-56. PMC: 1555264. View

Shek P, Sabiston B . Immune response mediated by liposome-associated protein antigens. II. Comparison of the effectiveness of vesicle-entrapped and surface-associated antigen in immunopotentiation. Immunology. 1982; 47(4):627-32. PMC: 1555561. View

Tom B, Goodwin T, Sengupta J, Kahan B, Rutzky L . A new approach for the immunogenic presentation of membrane-bound human colon tumor antigens. Immunol Commun. 1982; 11(4):315-23. DOI: 10.3109/08820138209050731. View

10.

van Rooijen N, van Nieuwmegen R . Association of an albumin antigen with phosphatidylcholine liposomes alters the nature of immunoglobulins produced during the immune response against the antigen. Biochim Biophys Acta. 1983; 755(3):434-8. DOI: 10.1016/0304-4165(83)90247-7. View

11.

Gerlier D, Bakouche O, Dore J . Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen. J Immunol. 1983; 131(1):485-90. View

12.

Shek P, Heath T . Immune response mediated by liposome-associated protein antigens. III. Immunogenicity of bovine serum albumin covalently coupled to vesicle surface. Immunology. 1983; 50(1):101-6. PMC: 1454241. View

13.

Snyder S, VANNIER W . Immunologic response to protein immobilized on the surface of liposomes via covalent azo-bonding. Biochim Biophys Acta. 1984; 772(3):288-94. DOI: 10.1016/0005-2736(84)90145-7. View

14.

Koff W, Fidler I . The potential use of liposome-mediated antiviral therapy. Antiviral Res. 1985; 5(3):179-90. PMC: 7173127. DOI: 10.1016/0166-3542(85)90050-6. View

15.

Warren H, Vogel F, Chedid L . Current status of immunological adjuvants. Annu Rev Immunol. 1986; 4:369-88. DOI: 10.1146/annurev.iy.04.040186.002101. View

16.

Claassen E, Kors N, van Rooijen N . Immunomodulation with liposomes: the immune response elicited by liposomes with entrapped dichloromethylene-diphosphonate and surface-associated antigen or hapten. Immunology. 1987; 60(4):509-15. PMC: 1453280. View

17.

Gregoriadis G, Davis D, Davies A . Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine. 1987; 5(2):145-51. DOI: 10.1016/0264-410x(87)90063-6. View

18.

Katz D, Benacerraf B . The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972; 15:1-94. DOI: 10.1016/s0065-2776(08)60683-5. View